BIIB logo

Biogen (BIIB)

Profile

Full Name

Biogen Inc.

Ticker Symbol

BIIB

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - General

Country

United States

IPO

September 17, 1991

Indexes

S&P 500,NASDAQ 100

Website

http://www.biogen.com

Employees

7605

Key Details

Price

$119.26(+3.55%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$9.68B(-1.62% YoY)

Annual EPS

$11.18(+40.28% YoY)

PE ratio

10.66

Next earnings date

Apr 24, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$119.26
BIIB price is $119.26

30-Day Relative Volume

0.88
BIIB 30-day relative volume is 0.88

Price Performance

Price Most recent change

+3.55%
BIIB price was up +3.55% on Apr 14, 2025

Price YTD change

-22.01%
BIIB price is down -22.01% since January 1st

Price 1-year change

-39.82%
BIIB price is down -39.82% year-on-year

Price 3-year change

-43.89%
BIIB price is down -43.89% over the past 3 years

Price Range

Price All-time high

$480.18
BIIB price is currently -75.16% below its historical high of $480.18

Price 3-year low

$110.04
BIIB price is currently +8.38% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$17.46B
BIIB market capitalization is $17.46 billion

Market cap 3-year change

-44.32%
BIIB market capitalization is down -44.32% over the past 3 years

Market cap All-time high

$111.67B
BIIB market capitalization is currently -84.37% below its historical high of $111.67 billion

Market cap sector rank

95.15%
BIIB market capitalization is higher than 95.15% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+1.09%
BIIB shares outstanding is up +1.09% year-on-year

Shares Outstanding 3-Year Change

-0.76%
BIIB shares outstanding is down -0.76% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.53
BIIB beta is 0.53

200-day SMA

$172.20
BIIB price is currently -30.74% below its 200-day simple moving average

50-day SMA

$137.39
BIIB price is currently -13.19% below its 50-day simple moving average

RSI

36.11
BIIB 14-day relative strength index is 36.11

Volume

0.88
BIIB 30-day relative volume is 0.88

ATR

$5.71
BIIB average true range is $5.71

10-day Historical Volatility

62.83%
BIIB 10-day historical volatility is 62.83%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$9.68B
BIIB annual revenue is $9.68 billion

Revenue Analysts estimate

$9.20B
BIIB annual revenue is currently +5.13% higher than the consensus analysts' forecast

Revenue 1-year change

-1.62%
BIIB annual revenue is down -1.62% year-on-year

Revenue Sector rank

94.06%
BIIB annual revenue is higher than 94.06% of companies in Healthcare sector

EPS

EPS

$11.18
BIIB annual earnings per share is $11.18

EPS Analysts estimate

$15.58
BIIB annual earnings per share is currently -28.25% lower than the consensus analysts' forecast

EPS 1-year change

+40.28%
BIIB annual earnings per share is up +40.28% year-on-year

EPS Sector rank

98.43%
BIIB annual earnings per share is higher than 98.43% of companies in Healthcare sector

Profit

Gross profit

$7.37B
BIIB annual gross profit is $7.37 billion

Gross margin

76.12%
BIIB annual gross profit margin is 76.12%

Operating profit

$2.22B
BIIB annual operating income is $2.22 billion

Operating margin

22.93%
BIIB annual operating profit margin is 22.93%

Net income

$1.63B
BIIB annual net profit is $1.63 billion

Net margin

16.87%
BIIB annual net profit margin is 16.87%

Expenses

Total expenses

$7.46B
BIIB annual total expenses is $7.46 billion

Operating expenses

$5.15B
BIIB annual total operating expenses is $5.15 billion

Cost of goods sold

$2.31B
BIIB annual cost of goods sold is $2.31 billion

Selling, general & administrative expenses

$2.40B
BIIB annual SGA is $2.40 billion

Depreciation and amortization

$673.20M
BIIB annual depreciation & amortization is $673.20 million

Interest expense

$250.30M
BIIB annual interest expense is $250.30 million

Income tax

$273.80M
BIIB annual income tax is $273.80 million

EBIT & EBITDA

EBIT

$2.16B
BIIB annual earnings before interest & taxes is $2.16 billion

EBITDA

$2.83B
BIIB annual EBITDA is $2.83 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$28.05B
BIIB annual total assets is $28.05 billion

Non current assets

$20.59B
BIIB annual long term assets is $20.59 billion

Current assets

$7.46B
BIIB annual total current assets is $7.46 billion

Cash and cash equivalents

$2.38B
BIIB annual cash & cash equivalents is $2.38 billion

Accounts receivable

$1.87B
BIIB annual accounts receivable is $1.87 billion

Inventory

$2.46B
BIIB annual inventory is $2.46 billion

Liabilities

Total liabilities

$11.33B
BIIB annual total liabilities is $11.33 billion

Long term liabilities

$5.80B
BIIB annual total long term liabilities is $5.80 billion

Current liabilities

$5.53B
BIIB annual total current liabilities is $5.53 billion

Accounts payable

$424.20M
BIIB annual accounts payable is $424.20 million

Debt

Total debt

$6.63B
BIIB annual total debt is $6.63 billion

Total debt 1-year change

-9.65%
BIIB annual total debt is down -9.65% year-on-year

Long term debt

$4.88B
BIIB annual long term debt is $4.88 billion

Short term debt

$1.75B
BIIB annual short term debt is $1.75 billion

Equity & Capital

Shareholders equity

$16.72B
BIIB annual stockholders equity is $16.72 billion

Book value

$16.72B
BIIB annual book value is $16.72 billion

Retained earnings

$19.26B
BIIB annual retained earnings is $19.26 billion

Working capital

$1.93B
BIIB annual working capital is $1.93 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$2.88B
BIIB annual cash flow from operations is $2.88 billion

Cash from operations 1-year change

+85.85%
BIIB annual cash flow from operations is up +85.85% year-on-year

Cash from investing

-$799.20M
BIIB annual cash flow from investing activities is -$799.20 million

Cash from investing 1-year change

+80.51%
BIIB annual cash flow from investing activities is up +80.51% year-on-year

Cash from financing

-$683.50M
BIIB annual cash flow from financing activities is -$683.50 million

Cash from financing 1-year change

-557.8%
BIIB annual cash flow from financing activities is down -557.8% year-on-year

CAPEX

CAPEX

$359.80M
BIIB annual capital expenditures is $359.80 million

CAPEX 1-year change

+15.54%
BIIB annual capital expenditures is up +15.54% year-on-year

Free Cash Flow

Free cash flow

$2.52B
BIIB annual free cash flow is $2.52 billion

Free cash flow 1-year change

+103.57%
BIIB annual free cash flow is up +103.57% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

76.12%
BIIB annual gross profit margin is 76.12%

Operating margin

22.93%
BIIB annual operating profit margin is 22.93%

Net margin

16.87%
BIIB annual net profit margin is 16.87%

ROA & ROE

ROA

5.95%
BIIB annual return on assets is 5.95%

ROE

10.36%
BIIB annual return on equity is 10.36%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

10.66
BIIB price to earnings ratio is 10.66

PE ratio Sector rank

15.69%
BIIB price to earnings ratio is higher than 15.69% of companies in Healthcare sector

PB Ratio

PB ratio

1.04
BIIB price to book ratio is 1.04

PB ratio Sector rank

44.9%
BIIB price to book ratio is higher than 44.9% of companies in Healthcare sector

PS Ratio

PS ratio

1.80
BIIB price to sales ratio is 1.80

PS ratio Sector rank

40.9%
BIIB price to sales ratio is higher than 40.9% of companies in Healthcare sector

Enterprise value

Enterprise value

$21.71B
BIIB enterprise value is $21.71 billion

Enterprise value Sector rank

95.05%
BIIB enterprise value is higher than 95.05% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

7.67
BIIB EV/EBITDA is 7.67

EV/EBITDA Sector rank

80.45%
BIIB EV/EBITDA is higher than 80.45% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.35
BIIB annual current ratio is 1.35

Quick ratio

0.90
BIIB annual quick ratio is 0.90

Leverage

Debt to equity

0.38
BIIB annual debt to equity ratio is 0.38

Interest coverage ratio

8.61
BIIB annual interest coverage ratio is 8.61

Risk & Stability

Piotroski F-Score

6
BIIB piotroski f-score is 6

Altman Z-Score

2.57
BIIB altman z-score is 2.57

Analyst ratings

Recent major analysts updates

Apr 9, 25 Morgan Stanley
Equal-Weight
Apr 4, 25 Argus Research
Hold
Feb 18, 25 Piper Sandler
Neutral
Feb 13, 25 Wells Fargo
Equal-Weight
Feb 13, 25 Truist Securities
Buy
Feb 13, 25 Scotiabank
Sector Outperform
Feb 13, 25 RBC Capital
Outperform
Feb 13, 25 Needham
Hold
Feb 13, 25 Morgan Stanley
Equal-Weight
Feb 13, 25 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

PODD logo
Insulet (PODD)
DGX logo
Quest Diagnostics Incorporated (DGX)
LH logo
Laboratory Corporation of America Holdings (LH)
COO logo
Cooper Companies (COO)
SMMT logo
Summit Therapeutics (SMMT)
TEVA logo
Teva Pharmaceutical Industries Limited (TEVA)
MOH logo
Molina Healthcare (MOH)
WST logo
West Pharmaceutical Services (WST)
WAT logo
Waters (WAT)
  • What is the ticker symbol for Biogen?
  • Does Biogen pay dividends?
  • What sector is Biogen in?
  • What industry is Biogen in?
  • What country is Biogen based in?
  • When did Biogen go public?
  • Is Biogen in the S&P 500?
  • Is Biogen in the NASDAQ 100?
  • Is Biogen in the Dow Jones?
  • When was Biogen's last earnings report?
  • When does Biogen report earnings?
  • Should I buy Biogen stock now?

What is the ticker symbol for Biogen?

The ticker symbol for Biogen is NASDAQ:BIIB

Does Biogen pay dividends?

No, Biogen does not pay dividends

What sector is Biogen in?

Biogen is in the Healthcare sector

What industry is Biogen in?

Biogen is in the Drug Manufacturers - General industry

What country is Biogen based in?

Biogen is headquartered in United States

When did Biogen go public?

Biogen's initial public offering (IPO) was on September 17, 1991

Is Biogen in the S&P 500?

Yes, Biogen is included in the S&P 500 index

Is Biogen in the NASDAQ 100?

Yes, Biogen is included in the NASDAQ 100 index

Is Biogen in the Dow Jones?

No, Biogen is not included in the Dow Jones index

When was Biogen's last earnings report?

Biogen's most recent earnings report was on Feb 12, 2025

When does Biogen report earnings?

The next expected earnings date for Biogen is Apr 24, 2025

Should I buy Biogen stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page